221 related articles for article (PubMed ID: 19567395)
1. Early modification of c-myc, Ha-ras and p53 expressions by chemical carcinogens (DMBA, MNU).
Budán F; Varjas T; Nowrasteh G; Prantner I; Varga Z; Ember A; Cseh J; Gombos K; Pázsit E; Gobel G; Bauer M; Gracza T; Arany I; Perjési P; Ember I; Kiss I
In Vivo; 2009; 23(4):591-8. PubMed ID: 19567395
[TBL] [Abstract][Full Text] [Related]
2. Early modification of c-myc, Ha-ras and p53 expressions by N-methyl-N-nitrosourea.
Budán F; Varjas T; Nowrasteh G; Varga Z; Boncz I; Cseh J; Prantner I; Antal T; Pázsit E; Gobel G; Bauer M; Gracza T; Perjési P; Ember I; Gyöngyi Z
In Vivo; 2008; 22(6):793-7. PubMed ID: 19181008
[TBL] [Abstract][Full Text] [Related]
3. Effect of E-2-(4'-methoxybenzylidene)-1-benzosuberone on the 7,12-dimethylbenz[alpha]anthracene-induced onco/suppressor gene action in vivo II: A 48-hour experiment.
Perjési P; Gyöngyi Z; Bayer Z
Anticancer Res; 2000; 20(3A):1839-48. PubMed ID: 10928116
[TBL] [Abstract][Full Text] [Related]
4. Effect of E-2-(4'-methoxybenzylidene)-1-benzosuberone on the 7,12-dimethylbenz[alpha]anthracene-induced onco/suppressor gene action in vivo. I: A 24-hour experiment.
Perjési P; Bayer Z; Ember I
Anticancer Res; 2000; 20(1A):475-81. PubMed ID: 10769699
[TBL] [Abstract][Full Text] [Related]
5. Changes in expression of onco- and suppressor genes in peripheral leukocytes--as potential biomarkers of chemical carcinogenesis.
Gyöngyi Z; Ember I; Kiss I; Varga C
Anticancer Res; 2001; 21(5):3377-80. PubMed ID: 11848497
[TBL] [Abstract][Full Text] [Related]
6. Deuterium depletion can decrease the expression of C-myc Ha-ras and p53 gene in carcinogen-treated mice.
Gyöngyi Z; Somlyai G
In Vivo; 2000; 14(3):437-9. PubMed ID: 10904878
[TBL] [Abstract][Full Text] [Related]
7. Effect of cisplatin treatment on early activation of oncogenes in vivo.
Németh A; Gyöngyi Z; Nádasi E; Ember A; Olasz L; Nyárády Z; Skapinyecz J; Ember I
In Vivo; 2002; 16(5):307-10. PubMed ID: 12494868
[TBL] [Abstract][Full Text] [Related]
8. Effect of rancid corn oil on some onco/suppressor gene expressions in vivo. A short-term study.
Perjési P; Pintér Z; Gyöngyi Z; Ember I
Anticancer Res; 2002; 22(1A):225-30. PubMed ID: 12017293
[TBL] [Abstract][Full Text] [Related]
9. Modulation of p53 and c-myc in DMBA-induced mammary tumors by oral glutamine.
Todorova VK; Kaufmann Y; Luo S; Klimberg VS
Nutr Cancer; 2006; 54(2):263-73. PubMed ID: 16898871
[TBL] [Abstract][Full Text] [Related]
10. In vivo effects of afobazole (2-mercaptobenzimidazole derivative) on the 7,12-dimethylbenz [alpha]anthracene-induced oncogene and suppressor gene expression.
Szanyi I; Lujber L; Gerlinger I; Pytel J; Bauer M; Csejtey A; Szele E; Gombos K; Kiss I; Seredenin S; Yarkova M; Ember I
In Vivo; 2007; 21(6):1059-63. PubMed ID: 18210756
[TBL] [Abstract][Full Text] [Related]
11. In vivo effects of cyclophosphamide on oncogene and suppressor gene expression in a "follow up" study.
Ember I; Kiss I
Anticancer Res; 1997; 17(5A):3593-7. PubMed ID: 9413208
[TBL] [Abstract][Full Text] [Related]
12. Effect of the chalcone analog E,E-bis(2-hydroxybenzylidene) acetone on the 7,12-dimethylbenz[a]anthracene-induced Ha-ras gene activity in vivo.
Perjési P; Ember I; Bozak RE; Nádasi E; Rozmer Z; Varjas T; Hicks RJ
In Vivo; 2006; 20(1):141-6. PubMed ID: 16433043
[TBL] [Abstract][Full Text] [Related]
13. Very early effect of DMBA and MNU on microRNA expression.
Juhász K; Gombos K; Szirmai M; Gőcze K; Wolher V; Révész P; Magda I; Sebestyén A; Németh A; Ember I
In Vivo; 2013; 27(1):113-7. PubMed ID: 23239859
[TBL] [Abstract][Full Text] [Related]
14. Effect of 7,12-dimethylbenz(a)anthracene on onco/suppressor gene action in vivo: a short-term experiment.
Ember I; Kiss I; Pusztai Z
Anticancer Res; 1998; 18(1A):445-7. PubMed ID: 9568117
[TBL] [Abstract][Full Text] [Related]
15. Mixtures of Uncaria and Tabebuia extracts are potentially chemopreventive in CBA/Ca mice: a long-term experiment.
Budán F; Szabó I; Varjas T; Nowrasteh G; Dávid T; Gergely P; Varga Z; Molnár K; Kádár B; Orsós Z; Kiss I; Ember I
Phytother Res; 2011 Apr; 25(4):493-500. PubMed ID: 20799345
[TBL] [Abstract][Full Text] [Related]
16. c-Ha-ras gene mutation and activation precede pathological changes in DMBA-induced in vivo carcinogenesis.
Kwong YY; Husain Z; Biswas DK
Oncogene; 1992 Aug; 7(8):1481-9. PubMed ID: 1630811
[TBL] [Abstract][Full Text] [Related]
17. Rapid induction of skin tumors in human but not mouse c-Ha-ras proto-oncogene transgenic mice by chemical carcinogenesis.
Muto S; Katsuki M; Horie S
Cancer Sci; 2006 Sep; 97(9):842-7. PubMed ID: 16805855
[TBL] [Abstract][Full Text] [Related]
18. Flow cytometric analysis of DMBA-induced early in vivo ras expression.
Gyöngyi Z; Grama L; Nádasi E; Sándor J; Németh A; Varga C; Kiss I; Ember I
In Vivo; 2002; 16(5):323-6. PubMed ID: 12494871
[TBL] [Abstract][Full Text] [Related]
19. Characterization of a preclinical model of simultaneous breast and ovarian cancer progression.
Ting AY; Kimler BF; Fabian CJ; Petroff BK
Carcinogenesis; 2007 Jan; 28(1):130-5. PubMed ID: 16891317
[TBL] [Abstract][Full Text] [Related]
20. Gpx2 is an overexpressed gene in rat breast cancers induced by three different chemical carcinogens.
Naiki-Ito A; Asamoto M; Hokaiwado N; Takahashi S; Yamashita H; Tsuda H; Ogawa K; Shirai T
Cancer Res; 2007 Dec; 67(23):11353-8. PubMed ID: 18056462
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
